Feb 8 (Reuters)-
Fuso Pharmaceutical Industries Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2017 Dec 31, 2016 Mar 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 35.45 36.20 47.30
(-2.1 pct) (+2.5 pct) (+1.1 pct)
Operating 785 mln 747 mln 800 mln
(+5.1 pct) (+33.0 pct) (+21.9 pct)
Recurring 809 mln 780 mln 800 mln
(+3.6 pct) (+55.9 pct) (+24.6 pct)
Net 943 mln 961 mln 1.00
(-1.9 pct) (+209.5 pct) (+16.1 pct)
EPS 106.37 yen 106.88 yen 112.21 yen
Ann Div 80.00 yen
-Q2 div 40.00 yen 4.00 yen
-Q4 div 40.00 yen 40.00 yen
NOTE - Fuso Pharmaceutical Industries Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T
((Tokyo Headline News Desk +813 6441 1812))